News – Archive

Grindeks awards the most outstanding Latvian scientists and grants D.H.Grindel award

The outstanding gastroenterologist professor Juris Pokrotnieks has been granted the Grindel award for lifetime achievement in Latvian medicine and pharmacy. While academician Ivars Kalvins, inventor...

13/10/2016

JSC Grindeks and World Anti-Doping Agency have agreed on cooperation

JSC Grindeks informs that on September 9 in Montreal, Canada at the invitation of the World Anti-Doping Agency representatives of the company met with the...

14/09/2016

Grindeks financial results in the first half year of 2016

Today, on 26 August, the JSC Grindeks submitted the non-audited consolidated financial statements for the first half year of 2016 to Nasdaq Riga. Non-audited financial...

26/08/2016

Annual Report and Corporate Social Responsibility Report 2015

Today, on 4 July, JSC Grindeks submitted to Nasdaq Riga the company’s Annual Report and the Corporate Social Responsibility Report for the year 2015, to...

04/07/2016

Decisions of Annual General Meeting of Shareholders of joint stock company Grindeks

1. Reports of Board, Supervisory Council, Audit Committee and statement of Sworn auditor To take notice of the reports of the Board, the Supervisory Council,...

07/06/2016

On Grindeks financial results in the three months of 2016

Today, on 27 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first quarter of 2016 to Nasdaq Riga. Non-audited financial results...

27/05/2016

Draft Resolutions of Annual General Meeting of Shareholders of JSC Grindeks to be held on 7 June 2016

Approved at the meeting of the Board of joint stock company Grindeks on 24 May 2016 and revised at the meeting of the Supervisory Council...

24/05/2016

On Grindeks audited results in 2015

Today, on 29 April, the JSC Grindeks submitted the audited consolidated financial statements of 2015 to Nasdaq Riga. Audited financial results indicate that the Group’s...

29/04/2016

Mildronate® is not a doping

JSC Grindeks, the manufacturer of Mildronate® (meldonium), has submitted an open letter to the World Anti-Doping Agency (WADA). According to the JSC Grindeks, WADA has...

18/04/2016